COST-EFFECTIVENESS OF A FIXED DOSE COMBINATION OF ALENDRONATE AND CHOLECALCIFEROL IN THE TREATMENT OF WOMEN WITH OSTEOPOROSIS AT RISK FOR VITAMIN D DEFICIENCY

被引：0
|
作者：
Ghosh, Sabyasachi [1 ]
Fan, Tao [2 ]
Modi, Ankita [2 ]
Jansen, Jeroen [1 ]
Sen, Shuvayu [2 ]
机构：
[1] MapiValues, Clin & Econ Evidence, Boston, MA USA
[2] Merck & Co Inc, Global Hlth Outcomes, Whitehouse Stn, NJ USA
来源：
OSTEOPOROSIS INTERNATIONAL | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：132 / 133
页数：2
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hiligsmann, M.
    Williams, S. A.
    Fitzpatrick, L. A.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S50 - S51
  • [22] The cost-effectiveness of risedronate treatment in Japanese women with osteoporosis
    Ding, Hansheng
    Koinuma, Nobuo
    Stevenson, Matt
    Ito, Michiya
    Monma, Yasutake
    JOURNAL OF BONE AND MINERAL METABOLISM, 2008, 26 (01) : 34 - 41
  • [23] Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronate
    Mobley, LR
    Hoerger, TJ
    Wittenborn, JS
    Galuska, DA
    Rao, JK
    MEDICAL DECISION MAKING, 2006, 26 (02) : 194 - 206
  • [24] Cost-effectiveness analysis of drugs for osteoporosis treatment in elderly Japanese women at high risk of fragility fractures: comparison of denosumab and weekly alendronate
    Yoshizawa, Tomohiro
    Nishino, Tomofumi
    Okubo, Ichiro
    Yamazaki, Masashi
    ARCHIVES OF OSTEOPOROSIS, 2018, 13 (01)
  • [25] Cost-effectiveness analysis of drugs for osteoporosis treatment in elderly Japanese women at high risk of fragility fractures: comparison of denosumab and weekly alendronate
    Tomohiro Yoshizawa
    Tomofumi Nishino
    Ichiro Okubo
    Masashi Yamazaki
    Archives of Osteoporosis, 2018, 13
  • [26] Cost-effectiveness Analysis of Sequential Treatment of Abaloparatide Followed by Alendronate Versus Teriparatide Followed by Alendronate in Postmenopausal Women With Osteoporosis in the United States
    Le, Quang A.
    Hay, Joel W.
    Becker, Russell
    Wang, Yamei
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (02) : 134 - 143
  • [27] Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy
    M. Hiligsmann
    S. Maggi
    N. Veronese
    L. Sartori
    J.-Y. Reginster
    Osteoporosis International, 2021, 32 : 595 - 606
  • [28] Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy
    Hiligsmann, M.
    Maggi, S.
    Veronese, N.
    Sartori, L.
    Reginster, J. -Y.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (03) : 595 - 606
  • [29] Cost-effectiveness of a fixed-dose combination agent in high-risk hypertensive patients
    Faulkner, MA
    Hilleman, DE
    Reyes, AP
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 105A - 105A
  • [30] Analysis of the cost-effectiveness of monotherapy versus fixed dose combination treatment of asthma in Republic of Moldova
    Corlateanu, Alexandru
    Botnaru, Victor
    Procoava, Ana
    Corlateanu, Olga
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
12345